Tacit Therapeutics

RNA gene therapy to treat genetic diseases

San Francisco, United States · Founded 2021 · $20.0M raised

Headquarters
San Francisco
Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$20.0M
Last Round
$19.0M Series AMar 2026
Rounds
2

About

Tacit Therapeutics is a San Francisco-based RNA gene therapy biotech founded in 2021 by David Nelles and colleagues. The company is developing broadly-applicable and non-immunogenic RNA gene therapy treatments for genetic diseases, with an initial focus on neurological conditions including Huntington's disease. Tacit uses trans-splicing technology that repurposes pre-existing components of human cells to replace large segments of broken RNA. The company launched publicly in 2024 with $19 million in funding.

Summary

Tacit Therapeutics is a Healthcare company based in San Francisco, United States, founded in 2021. It has raised $20.0M in total across 2 rounds, most recently a $19.0M Series A round in Mar 2026.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series ASeries AMar 2026
$19.0M

Sign up to see all 2 rounds

Grant through Series A — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tacit Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/tacit-therapeutics"><img src="https://indexed.vc/api/badge/company/tacit-therapeutics" alt="Tacit Therapeutics on Indexed.vc" width="260" height="76" /></a>